XML 40 R29.htm IDEA: XBRL DOCUMENT v3.24.3
Stockholders’ Deficit (Tables)
9 Months Ended
Sep. 30, 2024
Stockholders’ Deficit [Abstract]  
Schedule of Compensation Expense Related Restricted Stock Awards The table below summarizes the compensation expense related to the Company’s restricted stock awards for the nine months ended September 30:
   2024   2023 
Directors        
February 23, 2023: 168,419 share grant of common stock  $92,000   $
-
 
           
Consultants          
October 20, 2021: 17,274 share grant for common stock   
-
    154,000 
October 22, 2021: 8,637 share grant for common stock   
-
    66,000 
October 26, 2021: 17,274 share grant for common stock   
-
    129,000 
 August 23, 2023: 48,000 shares grant for common stock   
-
    24,000 
           
Employees          
June 19, 2023; 675,058 share grant of common stock   353,000    325,000 
April 4, 2022: 166,667 share grant for common stock   
-
    395,000 
Stock-based compensation expense reversal for April 4, 2022 grant   
-
    (1,910,000)
           
Other          
Officer contributed capital   
-
    188,000 
   $445,000   $(629,000)
Schedule of Service-Based RSUs The following table presents a summary of the activity of the service-based RSUs:
       Weighted Average 
       Grant-Date 
   Number of   Per Share 
   Units   Fair Value 
Balance as of January 1, 2024   730,967   $1.53 
Granted   
-
   $
-
 
Vested   (196,719)  $1.63 
Forfeited   
-
    
-
 
Balance as of September 30, 2024   534,248   $1.49 
Schedule of Warrants Transactions Transactions involving warrants are as follows for the nine months ended September 30, 2024:
   Number
of Shares
   Weighted
Average
Strike Price/Share
   Weighted Average Remaining
Contractual
Term (Years)
   Weighted
Average
Grant Date
Fair Value
   Weighted
Average
Intrinsic
Value
 
Outstanding – December 31, 2023   1,844,781   $9.84    1.39   $5.81   $1.19 
Granted   
-
    
-
    -    
-
    
-
 
Exercised   (165,622)   0.006    0.75    9.06    1.48 
Expired   (1,652,851)   10.98    -    7.55    
-
 
Outstanding – September 30, 2024   26,308    0.006    0.25    0.14    0.67 
Vested and exercisable – September 30, 2024   26,308    0.006    0.25    0.14    1.18 
Unvested and non-exercisable – September30, 2024   
-
   $
-
    -   $
-
   $
-